LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Seliciclib | 0.04 | uM | LJP5 | 72 | hr | 1694 | 11082 | 11103 | 0.9982 | 0.9986 |
MCF 10A | Seliciclib | 0.12 | uM | LJP5 | 72 | hr | 1694 | 10898 | 11103 | 0.9815 | 0.9859 |
MCF 10A | Seliciclib | 0.37 | uM | LJP5 | 72 | hr | 1694 | 10578 | 11103 | 0.9527 | 0.9644 |
MCF 10A | Seliciclib | 1.11 | uM | LJP5 | 72 | hr | 1694 | 10536 | 11103 | 0.9490 | 0.9614 |
MCF 10A | Seliciclib | 3.33 | uM | LJP5 | 72 | hr | 1694 | 10432 | 11103 | 0.9396 | 0.9544 |
MCF 10A | Seliciclib | 10 | uM | LJP5 | 72 | hr | 1694 | 4986 | 11103 | 0.4491 | 0.4887 |
MCF 10A | AT-7519 | 0.04 | uM | LJP6 | 72 | hr | 1694 | 11122 | 11217 | 0.9914 | 0.9935 |
MCF 10A | AT-7519 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 10552 | 11217 | 0.9407 | 0.9556 |
MCF 10A | AT-7519 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 6457 | 11217 | 0.5756 | 0.6332 |
MCF 10A | AT-7519 | 1.11 | uM | LJP6 | 72 | hr | 1694 | 623 | 11217 | 0.0556 | -0.3072 |
MCF 10A | AT-7519 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 314 | 11217 | 0.0280 | -0.4612 |
MCF 10A | AT-7519 | 10 | uM | LJP6 | 72 | hr | 1694 | 253 | 11217 | 0.0226 | -0.5030 |
MCF 10A | AZD7762 | 0.04 | uM | LJP6 | 72 | hr | 1694 | 9157 | 11217 | 0.8162 | 0.8563 |
MCF 10A | AZD7762 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 7703 | 11217 | 0.6867 | 0.7424 |
MCF 10A | AZD7762 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 6905 | 11217 | 0.6155 | 0.6739 |
MCF 10A | AZD7762 | 1.11 | uM | LJP6 | 72 | hr | 1694 | 5059 | 11217 | 0.4510 | 0.4929 |
MCF 10A | AZD7762 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 3091 | 11217 | 0.2757 | 0.2465 |
MCF 10A | AZD7762 | 10 | uM | LJP6 | 72 | hr | 1694 | 838 | 11217 | 0.0747 | -0.2306 |
MCF 10A | AZD8055 | 0.04 | uM | LJP6 | 72 | hr | 1694 | 6286 | 11217 | 0.5607 | 0.6156 |
MCF 10A | AZD8055 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 4177 | 11217 | 0.3724 | 0.3920 |
MCF 10A | AZD8055 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 3172 | 11217 | 0.2828 | 0.2586 |
MCF 10A | AZD8055 | 1.11 | uM | LJP6 | 72 | hr | 1694 | 2755 | 11217 | 0.2457 | 0.1952 |
MCF 10A | AZD8055 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 2536 | 11217 | 0.2261 | 0.1591 |
MCF 10A | AZD8055 | 10 | uM | LJP6 | 72 | hr | 1694 | 2374 | 11217 | 0.2117 | 0.1313 |
MCF 10A | Sorafenib | 0.04 | uM | LJP6 | 72 | hr | 1694 | 12063 | 11217 | 1.0756 | 1.0540 |